{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:56:44Z","timestamp":1781650604440,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Cancer Institute","award":["U01CA271410"],"award-info":[{"award-number":["U01CA271410"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45651-6","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T09:56:47Z","timestamp":1776506207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipidomic characterization of bile and serum reveals an altered lipid landscape in end-stage primary sclerosing cholangitis"],"prefix":"10.1038","volume":"16","author":[{"given":"Seul Kee","family":"Byeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saniha","family":"Sabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela S.","family":"Tietz-Bogert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadheshwar","family":"Balan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"O\u2019Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas F.","family":"LaRusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"45651_CR1","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","volume":"391","author":"JK Dyson","year":"2018","unstructured":"Dyson, J. K., Beuers, U., Jones, D. E. J., Lohse, A. W. & Hudson, M. Primary sclerosing cholangitis. Lancet 391, 2547\u20132559. https:\/\/doi.org\/10.1016\/S0140-6736(18)30300-3 (2018).","journal-title":"Lancet"},{"key":"45651_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030754","author":"C Vladut","year":"2020","unstructured":"Vladut, C. et al. An overview on primary sclerosing cholangitis. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm9030754 (2020).","journal-title":"J. Clin. Med."},{"key":"45651_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12016-019-08764-7","volume":"58","author":"J Song","year":"2020","unstructured":"Song, J. et al. Cholangiocarcinoma in patients with Primary Sclerosing Cholangitis (PSC): A comprehensive review. Clin. Rev. Allergy Immunol. 58, 134\u2013149. https:\/\/doi.org\/10.1007\/s12016-019-08764-7 (2020).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"45651_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3748\/wjg.v25.i6.659","volume":"25","author":"BM Fung","year":"2019","unstructured":"Fung, B. M., Lindor, K. D. & Tabibian, J. H. Cancer risk in Primary Sclerosing Cholangitis: Epidemiology, prevention, and surveillance strategies. World J. Gastroenterol. 25, 659\u2013671. https:\/\/doi.org\/10.3748\/wjg.v25.i6.659 (2019).","journal-title":"World J. Gastroenterol."},{"key":"45651_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.14218\/JCTH.2021.00344","volume":"10","author":"T Da Cunha","year":"2022","unstructured":"Da Cunha, T., Vaziri, H. & Wu, G. Y. Primary sclerosing cholangitis and inflammatory bowel disease: A review. J. Clin. Transl. Hepatol. 10, 531\u2013542. https:\/\/doi.org\/10.14218\/JCTH.2021.00344 (2022).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"45651_CR6","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1093\/ibd\/izad276","volume":"30","author":"J Cooper","year":"2024","unstructured":"Cooper, J. et al. Incidence and prevalence of Primary Sclerosing Cholangitis: A meta-analysis of population-based studies. Inflamm. Bowel Dis. 30, 2019\u20132026. https:\/\/doi.org\/10.1093\/ibd\/izad276 (2024).","journal-title":"Inflamm. Bowel Dis."},{"key":"45651_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s10620-019-05484-y","volume":"64","author":"ZP Fricker","year":"2019","unstructured":"Fricker, Z. P. & Lichtenstein, D. R. Primary Sclerosing Cholangitis: A concise review of diagnosis and management. Dig. Dis. Sci. 64, 632\u2013642. https:\/\/doi.org\/10.1007\/s10620-019-05484-y (2019).","journal-title":"Dig. Dis. Sci."},{"key":"45651_CR8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.4254\/wjh.v15.i8.939","volume":"15","author":"YR Shah","year":"2023","unstructured":"Shah, Y. R. et al. Liver transplant in Primary Sclerosing Cholangitis: Current trends and future directions. World J. Hepatol. 15, 939\u2013953. https:\/\/doi.org\/10.4254\/wjh.v15.i8.939 (2023).","journal-title":"World J. Hepatol."},{"key":"45651_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41575-022-00690-y","volume":"20","author":"JR Hov","year":"2023","unstructured":"Hov, J. R. & Karlsen, T. H. The microbiota and the gut-liver axis in Primary Sclerosing Cholangitis. Nat. Rev. Gastroenterol. Hepatol. 20, 135\u2013154. https:\/\/doi.org\/10.1038\/s41575-022-00690-y (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"45651_CR10","doi-asserted-by":"publisher","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","volume":"20","author":"H Cichoz-Lach","year":"2014","unstructured":"Cichoz-Lach, H. & Michalak, A. Oxidative stress as a crucial factor in liver diseases. World J. Gastroenterol. 20, 8082\u20138091. https:\/\/doi.org\/10.3748\/wjg.v20.i25.8082 (2014).","journal-title":"World J. Gastroenterol."},{"key":"45651_CR11","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.3748\/wjg.v26.i17.1993","volume":"26","author":"A Katsarou","year":"2020","unstructured":"Katsarou, A. et al. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. World J. Gastroenterol. 26, 1993\u20132011. https:\/\/doi.org\/10.3748\/wjg.v26.i17.1993 (2020).","journal-title":"World J. Gastroenterol."},{"key":"45651_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/00045391-200603000-00014","volume":"13","author":"G Gandelman","year":"2006","unstructured":"Gandelman, G., Aronow, W. S. & Weiss, M. B. Resolving hyperlipidemia after liver transplantation in a patient with primary sclerosing cholangitis. Am. J. Ther. 13, 171\u2013174. https:\/\/doi.org\/10.1097\/00045391-200603000-00014 (2006).","journal-title":"Am. J. Ther."},{"key":"45651_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1334865","volume":"11","author":"T Fererberger","year":"2024","unstructured":"Fererberger, T. et al. Distinct metabolomic and lipidomic profiles in serum samples of patients with primary sclerosing cholangitis. Front. Med. 11, 1334865. https:\/\/doi.org\/10.3389\/fmed.2024.1334865 (2024).","journal-title":"Front. Med."},{"key":"45651_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103188","volume":"19","author":"PS Tietz-Bogert","year":"2018","unstructured":"Tietz-Bogert, P. S. et al. Metabolomic profiling of portal blood and bile reveals metabolic signatures of primary sclerosing cholangitis. Int. J. Mol. Sci. 19, 3188. https:\/\/doi.org\/10.3390\/ijms19103188 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"45651_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/oby.20960","volume":"23","author":"VP Rachakonda","year":"2015","unstructured":"Rachakonda, V. P. et al. Serum autotaxin is independently associated with hepatic steatosis in women with severe obesity. Obesity 23, 965\u2013972. https:\/\/doi.org\/10.1002\/oby.20960 (2015).","journal-title":"Obesity"},{"key":"45651_CR16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos, A., de Gottardi, A. & Rescigno, M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J. Hepatol. 72, 558\u2013577. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.003 (2020).","journal-title":"J. Hepatol."},{"key":"45651_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1089\/omi.2023.0076","volume":"27","author":"JH Jung","year":"2023","unstructured":"Jung, J. H. et al. Characterization of lipid alterations by oncogenic PIK3CA mutations using untargeted lipidomics in breast cancer. OMICS 27, 327\u2013335. https:\/\/doi.org\/10.1089\/omi.2023.0076 (2023).","journal-title":"OMICS"},{"key":"45651_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jmsacl.2021.10.003","volume":"22","author":"SK Byeon","year":"2021","unstructured":"Byeon, S. K., Madugundu, A. K. & Pandey, A. Automated data-driven mass spectrometry for improved analysis of lipids with dual dissociation techniques. J. Mass Spectrom. Adv. Clin. Lab 22, 43\u201349. https:\/\/doi.org\/10.1016\/j.jmsacl.2021.10.003 (2021).","journal-title":"J. Mass Spectrom. Adv. Clin. Lab"},{"key":"45651_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7150\/ijbs.78525","volume":"19","author":"C Zhu","year":"2023","unstructured":"Zhu, C. et al. Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease. Int. J. Biol. Sci. 19, 311\u2013330. https:\/\/doi.org\/10.7150\/ijbs.78525 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"45651_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111554","volume":"544","author":"Y Li","year":"2022","unstructured":"Li, Y., Nicholson, R. J. & Summers, S. A. Ceramide signaling in the gut. Mol. Cell. Endocrinol. 544, 111554. https:\/\/doi.org\/10.1016\/j.mce.2022.111554 (2022).","journal-title":"Mol. Cell. Endocrinol."},{"key":"45651_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1006\/bbrc.1998.8983","volume":"248","author":"H Ikeda","year":"1998","unstructured":"Ikeda, H. et al. Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture. Biochem. Biophys. Res. Commun. 248, 436\u2013440. https:\/\/doi.org\/10.1006\/bbrc.1998.8983 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"45651_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2312666120","volume":"120","author":"I Sakuma","year":"2023","unstructured":"Sakuma, I. et al. Lysophosphatidic acid triggers inflammation in the liver and white adipose tissue in rat models of 1-acyl-sn-glycerol-3-phosphate acyltransferase 2 deficiency and overnutrition. Proc. Natl. Acad. Sci. U. S. A. 120, e2312666120. https:\/\/doi.org\/10.1073\/pnas.2312666120 (2023).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"45651_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3164\/jcbn.23-58","volume":"73","author":"H Tobita","year":"2023","unstructured":"Tobita, H. et al. Association of lysophosphatidic acid molecules with liver fibrosis: Different roles indicated. J. Clin. Biochem. Nutr. 73, 255\u2013261. https:\/\/doi.org\/10.3164\/jcbn.23-58 (2023).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"45651_CR24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/MPG.0000000000001044","volume":"62","author":"AE Kremer","year":"2016","unstructured":"Kremer, A. E. et al. Serum autotaxin activity correlates with pruritus in pediatric cholestatic disorders. J. Pediatr. Gastroenterol. Nutr. 62, 530\u2013535. https:\/\/doi.org\/10.1097\/MPG.0000000000001044 (2016).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"45651_CR25","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1053\/j.gastro.2010.05.009","volume":"139","author":"AE Kremer","year":"2010","unstructured":"Kremer, A. E. et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 139, 1008\u20131018. https:\/\/doi.org\/10.1053\/j.gastro.2010.05.009 (2010) (1018 e1001).","journal-title":"Gastroenterology"},{"key":"45651_CR26","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/hep.25748","volume":"56","author":"AE Kremer","year":"2012","unstructured":"Kremer, A. E. et al. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology 56, 1391\u20131400. https:\/\/doi.org\/10.1002\/hep.25748 (2012).","journal-title":"Hepatology"},{"key":"45651_CR27","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.lfs.2007.08.013","volume":"81","author":"N Watanabe","year":"2007","unstructured":"Watanabe, N. et al. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity. Life Sci 81, 1009\u20131015. https:\/\/doi.org\/10.1016\/j.lfs.2007.08.013 (2007).","journal-title":"Life Sci"},{"key":"45651_CR28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.bbrc.2007.08.078","volume":"362","author":"S Oka","year":"2007","unstructured":"Oka, S., Nakajima, K., Yamashita, A., Kishimoto, S. & Sugiura, T. Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem. Biophys. Res. Commun. 362, 928\u2013934. https:\/\/doi.org\/10.1016\/j.bbrc.2007.08.078 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"45651_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb3107","volume":"13","author":"CL Zimmer","year":"2021","unstructured":"Zimmer, C. L. et al. A biliary immune landscape map of primary sclerosing cholangitis reveals a dominant network of neutrophils and tissue-resident T cells. Sci. Transl. Med. 13, abb3107. https:\/\/doi.org\/10.1126\/scitranslmed.abb3107 (2021).","journal-title":"Sci. Transl. Med."},{"issue":"Suppl","key":"45651_CR30","doi-asserted-by":"publisher","first-page":"S237","DOI":"10.1194\/jlr.R800033-JLR200","volume":"50","author":"JE Burke","year":"2009","unstructured":"Burke, J. E. & Dennis, E. A. Phospholipase A2 structure\/function, mechanism, and signaling. J. Lipid Res. 50(Suppl), S237-242. https:\/\/doi.org\/10.1194\/jlr.R800033-JLR200 (2009).","journal-title":"J. Lipid Res."},{"key":"45651_CR31","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1111\/liv.14580","volume":"40","author":"S Salguero","year":"2020","unstructured":"Salguero, S. et al. Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV\/HCV-coinfected and HCV-monoinfected patients. Liver Int. 40, 2215\u20132227. https:\/\/doi.org\/10.1111\/liv.14580 (2020).","journal-title":"Liver Int."},{"key":"45651_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52621-x","volume":"15","author":"Y Tan","year":"2024","unstructured":"Tan, Y. et al. Lipid droplets sequester palmitic acid to disrupt endothelial ciliation and exacerbate atherosclerosis in male mice. Nat. Commun. 15, 8273. https:\/\/doi.org\/10.1038\/s41467-024-52621-x (2024).","journal-title":"Nat. Commun."},{"key":"45651_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jhep.2023.08.029","volume":"80","author":"E Kaffe","year":"2024","unstructured":"Kaffe, E. et al. Bioactive signalling lipids as drivers of chronic liver diseases. J. Hepatol. 80, 140\u2013154. https:\/\/doi.org\/10.1016\/j.jhep.2023.08.029 (2024).","journal-title":"J. Hepatol."},{"key":"45651_CR34","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/hep.29039","volume":"66","author":"JE Jang","year":"2017","unstructured":"Jang, J. E. et al. Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis in mice. Hepatology 66, 416\u2013431. https:\/\/doi.org\/10.1002\/hep.29039 (2017).","journal-title":"Hepatology"},{"key":"45651_CR35","doi-asserted-by":"publisher","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","volume":"20","author":"G Paradies","year":"2014","unstructured":"Paradies, G., Paradies, V., Ruggiero, F. M. & Petrosillo, G. Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World J. Gastroenterol. 20, 14205\u201314218. https:\/\/doi.org\/10.3748\/wjg.v20.i39.14205 (2014).","journal-title":"World J. Gastroenterol."},{"key":"45651_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115621","volume":"213","author":"M Anari","year":"2023","unstructured":"Anari, M. & Montgomery, M. K. Phospholipid metabolism in the liver - Implications for phosphatidylserine in non-alcoholic fatty liver disease. Biochem. Pharmacol. 213, 115621. https:\/\/doi.org\/10.1016\/j.bcp.2023.115621 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"45651_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021034","volume":"24","author":"S Shama","year":"2023","unstructured":"Shama, S. et al. Phosphatidylethanolamines are associated with nonalcoholic fatty liver disease (NAFLD) in obese adults and induce liver cell metabolic perturbations and hepatic stellate cell activation. Int. J. Mol. Sci. 24, 1034. https:\/\/doi.org\/10.3390\/ijms24021034 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"45651_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13112720","volume":"13","author":"K Weigand","year":"2025","unstructured":"Weigand, K. et al. Effect of Hepatitis C Virus genotype, cirrhosis, and viral cure on serum phosphatidylinositol species profiles. Biomedicines 13, 2720. https:\/\/doi.org\/10.3390\/biomedicines13112720 (2025).","journal-title":"Biomedicines"},{"key":"45651_CR39","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jhep.2021.06.043","volume":"75","author":"J Claria","year":"2021","unstructured":"Claria, J. et al. Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis. J. Hepatol. 75, 1116\u20131127. https:\/\/doi.org\/10.1016\/j.jhep.2021.06.043 (2021).","journal-title":"J. Hepatol."},{"key":"45651_CR40","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1194\/jlr.P056002","volume":"56","author":"DL Gorden","year":"2015","unstructured":"Gorden, D. L. et al. Biomarkers of NAFLD progression: A lipidomics approach to an epidemic. J. Lipid Res. 56, 722\u2013736. https:\/\/doi.org\/10.1194\/jlr.P056002 (2015).","journal-title":"J. Lipid Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45651-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45651-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45651-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:21:21Z","timestamp":1781648481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45651-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45651"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45651-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Mayo Clinic Institutional Review Board (IRB #13\u2013001312). The study was conducted in accordance with the relevant guidelines and regulations outlined in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"18066"}}